Now they've desperately thrown a bunch of shares at 1.38 into the cap. Must suck to be short, knowing that pretty soon we're going to have access to the Sullivan filing against the Rosen firm.
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links